GORE® SYNECOR Biomaterial is not authorized for use in Canada.

Designed for Intraperitoneal* and Preperitoneal† Placement

    GORE® SYNECOR Intraperitoneal Biomaterial Clinical Data Summary

    See data

    GORE® SYNECOR Preperitoneal Biomaterial Clinical Data Summary

    See data

    Prospective Study (SYN 20-01) in Progress1 

    Assessment of GORE® SYNECOR Biomaterial in focused Patient Populations and Long-Term Application

    • Sponsor: W. L. Gore & Associates, Inc.
    • Brief summary: The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application. Patients with ventral/incisional hernia amenable to hernia mesh repair will be enrolled into 2 cohorts (U.S. and EU) and followed-up over the period of 60 months.
    • Conditions: Hernia ventral, Hernia incisional, Hernia incisional ventral.
    • Enrollment: 320 anticipated.
    • 2 groups/cohorts. 

     

    Clinical Trials

    * GORE® SYNECOR Intraperitoneal Biomaterial.
    † GORE® SYNECOR Preperitoneal Biomaterial.

    1. W. L. Gore & Associates. Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application. NLM Identifier: NCT05094089. Published October 26, 2021. Updated July 5, 2022. Accessed October 10, 2022. https://clinicaltrials.gov/ct2/show/NCT05094089
    IFU Consult instructions

    Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly 

    INDICATIONS FOR USE: The GORE® SYNECOR Intraperitoneal Biomaterial device is intended for use in the repair of hernias and abdominal wall or thoracic wall soft tissue deficiencies that may require the addition of a nonabsorbable reinforcing or bridging material.

    CONTRAINDICATIONS: The GORE® SYNECOR Intraperitoneal Biomaterial is contraindicated for use in reconstruction of cardiovascular defects.

    INDICATIONS FOR USE: The GORE® SYNECOR Preperitoneal Biomaterial device is intended for use in the repair of hernias and abdominal wall soft tissue deficiencies that may require the addition of a non-absorbable reinforcing or bridging material. 

    CONTRAINDICATIONS: The GORE® SYNECOR Preperitoneal Biomaterial is contraindicated for use in reconstruction of cardiovascular defects.

    24GP1094-EN01